https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2014-11-30 17:15:002019-02-12 17:15:38Prof. Dr. Schirrmacher veröffentlicht E-Book: Harnessing Oncolytic Virus-mediated Antitumor Immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-27 / Cancer Res Treat 2015 Jul;47(3):518-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-27 / Cancer Res Treat 2015 Jul;47(3):518-262014-11-27 00:00:002019-02-15 08:46:10Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-26 / Biomaterials 2015 Feb;40:88-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-26 / Biomaterials 2015 Feb;40:88-972014-11-26 00:00:002019-02-15 08:39:35CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-24 / Technol. Cancer Res. Treat. 2015 Oct;14(5):607-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-24 / Technol. Cancer Res. Treat. 2015 Oct;14(5):607-152014-11-24 00:00:002014-11-24 00:00:00Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-15 / Immunobiology 2015 Feb;220(2):243-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-15 / Immunobiology 2015 Feb;220(2):243-82014-11-15 00:00:002019-02-15 08:39:36Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-07 / Eur. J. Immunol. 2014 Dec;44(12):3585-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-07 / Eur. J. Immunol. 2014 Dec;44(12):3585-952014-11-07 00:00:002019-02-15 08:45:48Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:912014-11-01 00:00:002014-11-01 00:00:00Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-702014-11-01 00:00:002019-02-15 08:47:43Emerging treatment strategies for glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-142014-11-01 00:00:002019-02-15 08:46:20Perspectives for immunotherapy in glioblastoma treatment
